CVS Health AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss increased by 233.8% to $5.27K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 74.9%, from $3.01K to $5.27K. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss shows an upward trend with a 27.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests short-term market headwinds affecting the bank's fixed-income assets.
This represents the accumulated unrealized losses on available-for-sale and trading debt securities that have been in a...
Standard disclosure for banks with large AFS portfolios subject to interest rate fluctuations.
afs_debt_securities_unrealized_loss_less_12m_acc| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.7K | 2.2K | 3.7K | 7.7K | 10.4K | 11.4K | 9.5K | 4.8K | 4.8K | 4.5K | 1.2K | 2.6K | 3.5K | 493 | 4.5K | 3K | 1.5K | 1.1K | 1.6K | 5.3K |
| QoQ Change | — | +34.9% | +65.0% | +108.7% | +34.5% | +9.4% | -16.4% | -49.5% | -0.1% | -5.8% | -73.8% | +122.9% | +32.7% | -85.9% | +813.2% | -33.1% | -49.3% | -27.4% | +42.2% | +233.8% |
| YoY Change | — | — | — | — | +524.4% | +406.6% | +156.8% | -37.9% | -53.9% | -60.3% | -87.6% | -45.1% | -27.0% | -89.1% | +280.9% | +14.3% | -56.3% | +125.2% | -64.9% | +74.9% |